ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer

Note: Funding Information: Janine Roodhart: Advisory role for Merck-Serono, Pierre Fabre, Servier, BMS, Roche, Bayer, GSK (all payments to institution). Institutional scientific grants from Bristol Myers Squibb, Merck, Delphi, HUB4 Organoids, Cleara, Pierre Fabre, Servier, Xilis, GSK.